Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin's Lymphoma

被引:0
作者
Liu, Shuxian [1 ]
Xu, Minghao [1 ]
Zhong, Lei [2 ]
Tong, Xiangmin [3 ]
Qian, Suying [4 ]
机构
[1] Hangzhou Normal Univ, Sch Pharm, Key Lab Elemene Class Anticanc Chinese Med, Hangzhou 311121, Zhejiang, Peoples R China
[2] Tongxiang Hosp Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China
[3] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou 310014, Peoples R China
[4] Ningbo No 2 Hosp, Ningbo, Peoples R China
关键词
B cell lymphoma; nanobiotechnology; non-hodgkin's lymphoma; combination therapy; nano biomaterials; diagnosis; DRUG-DELIVERY SYSTEM; B-CELL LYMPHOMA; T-CELL; DOXORUBICIN CHEMOTHERAPY; FDG-PET/CT; IN-VITRO; R-CHOP; THERAPY; NANOPARTICLES; EPIDEMIOLOGY;
D O I
10.2174/1389557523666230915103121
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lymphoma is the eighth most common type of cancer worldwide. Currently, lymphoma is mainly classified into two main groups: Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL), with NHL accounting for 80% to 90% of the cases. NHL is primarily divided into B, T, and natural killer (NK) cell lymphoma. Nanotechnology is developing rapidly and has made significant contributions to the field of medicine. This review summarizes the advancements of nanobiotechnology in recent years and its applications in the treatment of NHL, especially in diffuse large B cell lymphoma (DLBCL), primary central nervous system lymphoma (PCNSL), and follicular lymphoma (FL). The technologies discussed include clinical imaging, targeted drug delivery, photodynamic therapy (PDT), and thermodynamic therapy (TDT) for lymphoma. This review aims to provide a better understanding of the use of nanotechnology in the treatment of non-Hodgkin's lymphoma.
引用
收藏
页码:895 / 907
页数:13
相关论文
共 117 条
  • [1] Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
    Almeida, Bethany
    Nag, Okhil K.
    Rogers, Katherine E.
    Delehanty, James B.
    [J]. MOLECULES, 2020, 25 (23):
  • [2] Non-Hodgkin Lymphoma: Diagnosis and Treatment
    Ansell, Stephen M.
    [J]. MAYO CLINIC PROCEEDINGS, 2015, 90 (08) : 1152 - 1163
  • [3] Non-Hodgkin lymphoma
    Armitage, James O.
    Gascoyne, Randy D.
    Lunning, Matthew A.
    Cavalli, Franco
    [J]. LANCET, 2017, 390 (10091) : 298 - 310
  • [4] Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors
    Arumov, Artavazd
    Liyanage, Piumi Y.
    Trabolsi, Asaad
    Roberts, Evan R.
    Li, Lingxiao
    Ferreira, Braulio C. L. B.
    Gao, Zhen
    Ban, Yuguang
    Newsam, Austin D.
    Taggart, Melissa W.
    Vega, Francisco
    Bilbao, Daniel
    Leblanc, Roger M.
    Schatz, Jonathan H.
    [J]. CANCER RESEARCH, 2021, 81 (03) : 763 - 775
  • [5] Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review
    Asano, Naoki
    Iijima, Katsunori
    Koike, Tomoyuki
    Imatani, Akira
    Shimosegawa, Tooru
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (26) : 8014 - 8020
  • [6] Application of Nanoparticles and Nanomaterials in Thermal Ablation Therapy of Cancer
    Ashikbayeva, Zhannat
    Tosi, Daniele
    Balmassov, Damir
    Schena, Emiliano
    Saccomandi, Paola
    Inglezakis, Vassilis
    [J]. NANOMATERIALS, 2019, 9 (09)
  • [7] Magnetic Nanoparticles as MRI Contrast Agents
    Avasthi, Ashish
    Caro, Carlos
    Pozo-Torres, Esther
    Leal, Manuel Pernia
    Garcia-Martin, Maria Luisa
    [J]. TOPICS IN CURRENT CHEMISTRY, 2020, 378 (03)
  • [8] The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine
    Bayda, Samer
    Adeel, Muhammad
    Tuccinardi, Tiziano
    Cordani, Marco
    Rizzolio, Flavio
    [J]. MOLECULES, 2020, 25 (01):
  • [9] Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
    Billingsley, Margaret M.
    Singh, Nathan
    Ravikumar, Pranali
    Zhang, Rui
    June, Carl H.
    Mitchell, Michael J.
    [J]. NANO LETTERS, 2020, 20 (03) : 1578 - 1589
  • [10] Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment
    Bock, Allison M.
    Nowakowski, Grzegorz S.
    Wang, Yucai
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (02) : 155 - 170